Step 1 topics → Renal → Membranous Nephropathy

Membranous Nephropathy

USMLE Step 1 trap: Confuses membranous spike-and-dome EM pattern (subepithelial deposits with GBM spikes) with MPGN tram-track GBM duplication. Spike-and-dome on EM represents GBM projections (spikes) growing up between subepithelial immune deposits (domes), not GBM duplication as seen in MPGN.

Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in non-diabetic adults, and USMLE Step 1 will test it hard. The core pathophysiology is immune complex deposition in the subepithelial space — between the podocyte foot processes and the GBM — which triggers complement activation, podocyte injury, and massive proteinuria. The classic primary form is driven by IgG4 autoantibodies against PLA2R (phospholipase A2 receptor) on podocytes. Secondary causes matter just as much for the exam: HBV, lupus (class V), solid tumors, and NSAIDs/penicillamine are the big ones.

The exam tests MN from three main angles: recognizing the clinical presentation (middle-aged adult with nephrotic-range proteinuria plus a specific complication), interpreting biopsy findings across all three modalities (LM, IF, EM), and distinguishing primary from secondary disease based on serologic or clinical clues. USMLE Step 1 loves to embed this in a vignette with a biopsy description — you need to know what spike-and-dome means, where the deposits sit on EM, and what immunofluorescence shows.

What makes MN tricky is the overlap with other glomerular diseases. Students frequently confuse the spike-and-dome EM pattern with MPGN's tram-track appearance, mix up which hepatitis virus causes which glomerulonephritis, and invert the PLA2R interpretation (positive means primary — not secondary). The thrombosis risk is also under-appreciated: MN has the highest renal vein thrombosis risk of any nephrotic syndrome, and that clinical pearl appears on the exam more than most students expect.

From real student decks
65%have cards covering this topic
46%have mature cards

Common misconceptions

Common mistake
Wrong: The spike-and-dome pattern on EM in membranous nephropathy represents GBM duplication.
Right: Spike-and-dome on EM represents GBM projections (spikes) growing up between subepithelial immune deposits (domes), not GBM duplication as seen in MPGN.
Spike-and-dome on EM is not GBM duplication — that's MPGN's tram-track pattern, which involves mesangial cell interposition into the capillary wall. In membranous nephropathy, the GBM responds to subepithelial immune deposits by growing new matrix projections (the 'spikes') up between them; the deposits themselves are the 'domes.' Two completely different structural mechanisms, two different diseases.
Common mistake
Wrong: A positive PLA2R antibody indicates a secondary cause of membranous nephropathy.
Right: Positive anti-PLA2R antibody indicates primary (idiopathic) membranous nephropathy; a negative PLA2R should prompt workup for secondary causes such as HBV, malignancy, or lupus.
The logic runs opposite to what many students assume: a positive anti-PLA2R antibody confirms that the patient's own immune system is attacking podocyte PLA2R — that's the primary (idiopathic) autoimmune form. When PLA2R is negative, the deposits are being driven by something else (HBV antigen, tumor antigen, lupus), so a negative result is the trigger to look for a secondary cause, not reassurance that the disease is idiopathic.
Common mistake
Gap: Missing that HBV (not HCV) is the viral secondary cause of membranous nephropathy; HCV causes MPGN
Hepatitis B (not hepatitis C) is the classic viral secondary cause of membranous nephropathy; HCV is more associated with MPGN via cryoglobulinemia.
HBV and HCV cause different glomerular diseases through different mechanisms. HBV deposits its surface and e-antigens in the subepithelial space, producing an immune complex pattern identical to primary membranous nephropathy. HCV causes mixed cryoglobulinemia, and those cryoglobulins lodge in the mesangium and subendothelial space — the hallmark of MPGN with tram-track, not spike-and-dome.
Common mistake
Gap: Missing that membranous nephropathy has the highest renal vein thrombosis risk among nephrotic diseases
Membranous nephropathy carries the highest risk of renal vein thrombosis among the nephrotic syndromes, due to severe proteinuria and urinary loss of antithrombin III.
Membranous nephropathy causes more severe, sustained proteinuria than most other nephrotic diseases, and antithrombin III is a small enough protein that it leaks out in the urine along with albumin. This creates a hypercoagulable state that specifically predisposes to renal vein thrombosis — the largest renal venous drainage is vulnerable to sluggish, prothrombotic flow. Clinically this presents as flank pain, worsening proteinuria, and hematuria; on the exam it's the complication most closely linked to MN specifically.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the classic presentation: middle-aged adult (often male) with nephrotic syndrome and the highest renal vein thrombosis risk among all nephrotic diseases — be ready to identify this clinically or explain the mechanism (loss of antithrombin III in urine).
  2. Interpret biopsy findings at all three levels: LM shows diffuse capillary wall thickening without hypercellularity; IF shows granular IgG and C3 deposits along the GBM; EM shows subepithelial electron-dense deposits with GBM spikes projecting up between them (spike-and-dome).
  3. Distinguish primary from secondary membranous nephropathy: anti-PLA2R antibody positive = primary (idiopathic); anti-PLA2R negative = work up for secondary causes including HBV, malignancy (lung, colon), SLE class V, and drugs (NSAIDs, gold, penicillamine).

Can you avoid these mistakes?

A 52-year-old man has nephrotic syndrome. Renal biopsy shows diffuse capillary wall thickening on LM, granular IgG deposits along the GBM on IF, and subepithelial electron-dense deposits with 'spike' projections of GBM matrix on EM. Serologies show positive anti-PLA2R antibodies. What is the diagnosis, and does this patient need workup for malignancy or hepatitis?
A patient with membranous nephropathy develops sudden-onset left flank pain and worsening proteinuria. What complication do you suspect, what is the mechanism, and which specific protein loss makes this patient hypercoagulable?
On EM, what distinguishes membranous nephropathy from MPGN? Where are the deposits located in each, and what structural change defines each pattern?
A 38-year-old woman with known SLE develops nephrotic syndrome. Biopsy shows membranous pattern (subepithelial deposits, spike-and-dome EM) but anti-PLA2R is negative. What WHO/ISN class of lupus nephritis is this, and why does the negative PLA2R support rather than argue against a secondary cause?

Related topics

Nephrotic Syndrome — Pattern and Differential Kidney Development (Pro-/Meso-/Metanephros) Congenital Renal Anomalies Nephron Structure and Segments Renal Vasculature (Afferent / Efferent / Vasa Recta)

See how your Anki deck covers this topic.

Upload your deck for a free audit →